Alberti, KG, Zimmet, P & Shaw, J. Metabolic syndrome — a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet. Med. 23, 469–480 (2006).
Brown, AE & Walker, M. Genetics of insulin resistance and the metabolic syndrome. Curr. Cardiol. Rep. 18, 75 (2016).
Kovatcheva-Datchary, P & Arora, T. Nutrition, the gut microbiome and the metabolic syndrome. Best Pract. Res. Clin. Gastroenterol. 27, 59–72 (2013).
Parekh, PJ, Balart, LA & Johnson, DA. The influence of the gut microbiome on obesity, metabolic syndrome and gastrointestinal disease. Clin. Transl. Gastroenterol. 6, e91 (2015).
Vijay-Kumar, M et al. Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science 328, 228–231 (2010).
Di Luccia, B et al. Rescue of fructose-induced metabolic syndrome by antibiotics or faecal transplantation in a rat model of obesity. PLoS ONE 10, e0134893 (2015).
Ley, RE, Turnbaugh, PJ, Klein, S & Gordon, JI. Microbial ecology: human gut microbes associated with obesity. Nature 444, 1022–1023 (2006).
Ridaura, VK et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science 341, 1241214 (2013).
Steinhardt, AP et al. A functional nonsynonymous toll-like receptor 4 gene polymorphism is associated with metabolic syndrome, surrogates of insulin resistance, and syndromes of lipid accumulation. Metabolism 59, 711–717 (2010).
Jialal, I, Huet, BA, Kaur, H, Chien, A & Devaraj, S. Increased toll-like receptor activity in patients with metabolic syndrome. Diabetes Care 35, 900–904 (2012).
Hardy, OT, Kim, A, Ciccarelli, C, Hayman, LL & Wiecha, J. Increased Toll-like receptor (TLR) mRNA expression in monocytes is a feature of metabolic syndrome in adolescents. Pediatr. Obes. 8, e19–e23 (2013).
Gay, NJ, Symmons, MF, Gangloff, M & Bryant, CE. Assembly and localization of Toll-like receptor signalling complexes. Nat. Rev. Immunol. 14, 546–558 (2014).
O'Neill, LA, Golenbock, D & Bowie, AG. The history of Toll-like receptors — redefining innate immunity. Nat. Rev. Immunol. 13, 453–460 (2013).
Pierre, N, Deldicque, L, Barbe, C, Naslain, D, Cani, PD & Francaux, M. Toll-like receptor 4 knockout mice are protected against endoplasmic reticulum stress induced by a high-fat diet. PLoS ONE 8, e65061 (2013).
Kim, F et al. Toll-like receptor-4 mediates vascular inflammation and insulin resistance in diet-induced obesity. Circ. Res. 100, 1589–1596 (2007).
Shi, H, Kokoeva, MV, Inouye, K, Tzameli, I, Yin, H & Flier, JS. TLR4 links innate immunity and fatty acid-induced insulin resistance. J. Clin. Invest. 116, 3015–3025 (2006).
Kanwar, P & Kowdley, KV. The metabolic syndrome and its influence on nonalcoholic steatohepatitis. Clin. Liver Dis. 20, 225–243 (2016).
Fujisaka, S et al. Regulatory mechanisms for adipose tissue M1 and M2 macrophages in diet-induced obese mice. Diabetes 58, 2574–2582 (2009).
Lozupone, C & Knight, R. UniFrac: a new phylogenetic method for comparing microbial communities. Appl. Environ. Microbiol. 71, 8228–8235 (2005).
Bevins, CL & Salzman, NH. Paneth cells, antimicrobial peptides and maintenance of intestinal homeostasis. Nat. Rev. Microbiol. 9, 356–368 (2011).
Saberi, M et al. Hematopoietic cell-specific deletion of toll-like receptor 4 ameliorates hepatic and adipose tissue insulin resistance in high-fat-fed mice. Cell Metab. 10, 419–429 (2009).
Tsukumo, DM et al. Loss-of-function mutation in Toll-like receptor 4 prevents diet-induced obesity and insulin resistance. Diabetes 56, 1986–1998 (2007).
Jia, L et al. Hepatocyte Toll-like receptor 4 regulates obesity-induced inflammation and insulin resistance. Nat. Commun. 5, 3878 (2014).
Musso, G, Gambino, R & Cassader, M. Interactions between gut microbiota and host metabolism predisposing to obesity and diabetes. Annu. Rev. Med. 62, 361–380 (2011).
Tremaroli, V & Backhed, F. Functional interactions between the gut microbiota and host metabolism. Nature 489, 242–249 (2012).
Sonnenburg, JL & Backhed, F. Diet-microbiota interactions as moderators of human metabolism. Nature 535, 56–64 (2016).
Nicholson, JK et al. Host-gut microbiota metabolic interactions. Science 336, 1262–1267 (2012).
Hooper, LV. Bacterial contributions to mammalian gut development. Trends Microbiol. 12, 129–134 (2004).
Li, M et al. Gut carbohydrate metabolism instead of fat metabolism regulated by gut microbes mediates high-fat diet-induced obesity. Benef. Microbes 5, 335–344 (2014).
Sodhi, CP et al. Intestinal epithelial Toll-like receptor 4 regulates goblet cell development and is required for necrotizing enterocolitis in mice. Gastroenterology 143, 708–718 e701–705 (2012).
Johansson, ME et al. Composition and functional role of the mucus layers in the intestine. Cell. Mol. Life Sci. 68, 3635–3641 (2011).
Wittkopf, N et al. Lack of intestinal epithelial atg7 affects paneth cell granule formation but does not compromise immune homeostasis in the gut. Clin. Dev. Immunol. 2012, 278059 (2012).
Stockinger, S et al. TRIF signaling drives homeostatic intestinal epithelial antimicrobial peptide expression. J. Immunol. 193, 4223–4234 (2014).
Hutton, MJ, Soukhatcheva, G, Johnson, JD & Verchere, CB. Role of the TLR signaling molecule TRIF in beta-cell function and glucose homeostasis. Islets 2, 104–111 (2010).
Pineda Torra, I, Gervois, P & Staels, B. Peroxisome proliferator-activated receptor alpha in metabolic disease, inflammation, atherosclerosis and aging. Curr. Opin. Lipidol. 10, 151–159 (1999).
Evans, RM, Barish, GD & Wang, YX. PPARs and the complex journey to obesity. Nat. Med. 10, 355–361 (2004).
Dasu, MR, Park, S, Devaraj, S & Jialal, I. Pioglitazone inhibits Toll-like receptor expression and activity in human monocytes and db/db mice. Endocrinology 150, 3457–3464 (2009).
Appel, S, Mirakaj, V, Bringmann, A, Weck, MM, Grunebach, F & Brossart, P. PPAR-gamma agonists inhibit toll-like receptor-mediated activation of dendritic cells via the MAP kinase and NF-kappaB pathways. Blood 106, 3888–3894 (2005).
Rodriguez-Calvo, R et al. Activation of peroxisome proliferator-activated receptor beta/delta inhibits lipopolysaccharide-induced cytokine production in adipocytes by lowering nuclear factor-kappaB activity via extracellular signal-related kinase 1/2. Diabetes 57, 2149–2157 (2008).
Eun, CS et al. Attenuation of colonic inflammation by PPARgamma in intestinal epithelial cells: effect on Toll-like receptor pathway. Dig. Dis. Sci. 51, 693–697 (2006).
Cani, PD et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56, 1761–1772 (2007).
Kliewer, SA et al. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma. Proc. Natl. Acad. Sci. USA 94, 4318–4323 (1997).
Costet, P, Legendre, C, More, J, Edgar, A, Galtier, P & Pineau, T. Peroxisome proliferator-activated receptor alpha-isoform deficiency leads to progressive dyslipidemia with sexually dimorphic obesity and steatosis. J. Biol. Chem. 273, 29577–29585 (1998).
Chen, X et al. Improvement of dyslipidemia, insulin sensitivity, and energy balance by a peroxisome proliferator-activated receptor alpha agonist. Metab. Clin. Exp. 57, 1516–1525 (2008).
Chassaing, B, Ley, RE & Gewirtz, AT. Intestinal epithelial cell toll-like receptor 5 regulates the intestinal microbiota to prevent low-grade inflammation and metabolic syndrome in mice. Gastroenterology 147, 1363–1377 e1317 (2014).
Hosoi, T, Yokoyama, S, Matsuo, S, Akira, S & Ozawa, K. Myeloid differentiation factor 88 (MyD88)-deficiency increases risk of diabetes in mice. PLoS ONE 5, 9 (2010).
Subramanian, M, Ozcan, L, Ghorpade, DS, Ferrante, AW Jr. & Tabas, I. Suppression of adaptive immune cell activation does not alter innate immune adipose inflammation or insulin resistance in obesity. PLoS ONE 10, e0135842 (2015).
Everard, A et al. Intestinal epithelial MyD88 is a sensor switching host metabolism towards obesity according to nutritional status. Nat. Commun. 5, 5648 (2014).
Yu, M et al. MyD88-dependent interplay between myeloid and endothelial cells in the initiation and progression of obesity-associated inflammatory diseases. J. Exp. Med. 211, 887–907 (2014).
Afrazi, A et al. Toll-like receptor 4-mediated endoplasmic reticulum stress in intestinal crypts induces necrotizing enterocolitis. J. Biol. Chem. 289, 9584–9599 (2014).
Van Heek, M et al. Diet-induced obese mice develop peripheral, but not central, resistance to leptin. J. Clin. Invest. 99, 385–390 (1997).
Johnson, DH, Narayan, S, Wilson, DL & Flask, CA. Body composition analysis of obesity and hepatic steatosis in mice by relaxation compensated fat fraction (RCFF) MRI. J. Magn. Reson. Imaging 35, 837–843 (2012).
Beguinot, F & Nigro, C. Measurement of glucose homeostasis in vivo: glucose and insulin tolerance tests. Methods Mol. Biol. 933, 219–228 (2012).